Rozek Elizabeth 4

What Happened Elizabeth Rozek, Chief Legal & Administrative Officer of Sagimet Biosciences (SGMT), sold 2,622 shares on February 10, 2026, at $5.36 per share for total proceeds of $14,054. The sale was reported as an open-market or private sale (code S) and was executed to satisfy tax-withholding obligations tied to the vesting of restricted stock units (RSUs). This was a sale (often a routine, non-bullish signal) rather than a purchase.

Key Details

• Transaction date: 2026-02-10; Price: $5.36 per share; Shares sold: 2,622; Proceeds: $14,054.
• Transaction type/code: Sale (S); reported method: open market or private sale.
• Footnote (F1): Sale was automatic to cover tax withholding on vested RSUs and was not at the reporting person’s discretion.
• Shares owned after transaction: Not disclosed in the filing excerpt.
• Filing date: 2026-02-12 — appears to be filed timely (within standard 2 business days).

Context This transaction was a tax-withholding/settlement sale related to RSU vesting (often labeled with footnote F). Such automatic withholding sales are routine administrative actions and do not necessarily reflect the insider’s view on the company’s prospects. For retail investors, purchases by insiders can be more informative about sentiment; sales like this are commonly procedural.